Clinical Trial Patient Activation (CTPA)
GRYT’s “CTPA” is a proven solution to drive recruitment and support representation on high-priority clinical trials.
We developed our innovative approach through successful collaboration with sponsors to:
- Position clinical trials with clearly articulated differentiators 
- Increase awarenesss with physicians and patients based on targeted geo and demographic factors – particularly for underrepresented patients 
- Utilize a scalable approach with real-time engagement and conversion analytics 
- Demonstrate results and optimize efforts with bi-weekly reporting 
Over the past decade, Gryt’s innovative CTPA solution has successfully enrolled high-priority trials and helped our clients achieve FDA goals.
After working with Lilly COI and leading LIVESTRONG’S Clinical Trial Matching Service, David Craig co-founded Gryt Health in 2016.
- Gryt’s first client was Ignyta, where we helped successfully enroll its NTRK trial 
- Gryt was awarded the Participant Engagement Award at SCOPE in 2019 and 2021 
Engagement by Site Location
Each pin represents a person searching on Google, saw the campaign, utilized Gryt’s engagement platform and then took action for enrollment.
Outcomes Achieved
- Facilitated patient-focused trial education, boosting awareness and screening 
- Engaged underrepresented patients by race, ethnicity & rural settings 
- Delivered actionable insights/ analytics for overall and site-specific recruitment 
- Increased patient diversity in screening 
- KPI’s are utilized to complete the read-out for FDA Diversity Action Plan 


 
            
              
            
            
          
               
            
              
            
            
          
               
            
              
            
            
          
              